Jinyun Dong

2.6k total citations · 2 hit papers
65 papers, 2.1k citations indexed

About

Jinyun Dong is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jinyun Dong has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Organic Chemistry and 22 papers in Oncology. Recurrent topics in Jinyun Dong's work include Synthesis and biological activity (12 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (11 papers). Jinyun Dong is often cited by papers focused on Synthesis and biological activity (12 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (11 papers). Jinyun Dong collaborates with scholars based in China, United States and Macao. Jinyun Dong's co-authors include Jiang‐Jiang Qin, Xiangdong Cheng, Shaoshun Li, Qijing Zhang, G. Huang, Weidong Zhang, Qingqing Meng, Zhiyuan Xu, Zengtao Wang and Weidong Zhang and has published in prestigious journals such as Nature Communications, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Jinyun Dong

63 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

2021 209 citations Jinyun Dong, Zhiyuan Xu et al. Frontiers in Pharmacology profile →
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review

2023 85 citations Jinyun Dong, Yuan Li et al. Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by Jinyun Dong

Since Specialization

Citations

This map shows the geographic impact of Jinyun Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyun Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyun Dong more than expected).

Fields of papers citing papers by Jinyun Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyun Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyun Dong. The network helps show where Jinyun Dong may publish in the future.

Co-authorship network of co-authors of Jinyun Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyun Dong. A scholar is included among the top collaborators of Jinyun Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyun Dong. Jinyun Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An updated review on the role of small molecules in mediating protein degradation 2025 ·European Journal of Medicinal Chemistry ·(unknown), Yulong Li, Jinyun Dong, Jiang‐Jiang Qin	4
2	HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment 2025 ·Advanced Science ·Jinyun Dong, Yulong Li, Hui Liang, (unknown), Shiqun Wang, Yichao Wang, (unknown), (unknown), Maohua Cai, Guangzhao Pan, Haiyan Yang, (unknown), Zhe‐Sheng Chen, Fangfang Tao, Xuelei Ma, Jiang‐Jiang Qin	1
3	A comprehensive proteomic analysis uncovers novel molecular subtypes of gastric signet ring cell carcinoma: Identification of potential prognostic biomarkers and therapeutic targets 2025 ·Genes & Diseases ·(unknown), Yuan Li, (unknown), Zu Ye, Zhao Zhang, Yi Wang, Caihong Hu, Jinyun Dong, Xinuo Zhang, Zhiyuan Xu, (unknown), Xiaoqing Guan, Guangzhao Pan, (unknown), Juan Li, Ruiwen Zhang, Jiang‐Jiang Qin, Xiangdong Cheng	0
4	Hierarchical hazard-accident causal network analysis for offshore platform safety assessment 2025 ·Process Safety and Environmental Protection ·Jinyun Dong, (unknown), X. B. Ji, Zheng Wang, Fengli Zhang	0
5	ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation 2024 ·European Journal of Medicinal Chemistry ·(unknown), Yulong Li, Maohua Cai, Wenyan Yang, (unknown), Jinyun Dong, Jiang‐Jiang Qin	14
6	Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis 2024 ·Journal of Medicinal Chemistry ·Jinyun Dong, (unknown), Maohua Cai, (unknown), Haobin Li, Hui Liang, Yulong Li, Guangyu Ding, Juan Li, (unknown), Jiang‐Jiang Qin	17
7	Small molecule inhibitors targeting heat shock protein 90: An updated review 2024 ·European Journal of Medicinal Chemistry ·Yulong Li, Jinyun Dong, Jiang‐Jiang Qin	10
8	Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance 2024 ·Scientific Reports ·Weihui Zheng, Xi Tang, Jinyun Dong, Jianguo Feng, Min Chen, Xin Zhu	2
9	Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway 2023 ·Frontiers in Pharmacology ·Jing Zhao, (unknown), Yubo Ma, Li‐Bin Pan, Yanan Wang, Yuan Li, Jinyun Dong, Jieer Ying	6
10	Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance 2023 ·RSC Medicinal Chemistry ·(unknown), Yulong Li, (unknown), (unknown), Zheshen Li, Zhe‐Sheng Chen, Xiangdong Cheng, Jiang‐Jiang Qin, Jinyun Dong	12
11	Integrative proteomic characterization of adenocarcinoma of esophagogastric junction 2023 ·Nature Communications ·Shengli Li, Yuan Li, Zhiyuan Xu, Jingli Xu, Guiping Chen, Xiaoqing Guan, (unknown), Can Hu, Jinyun Dong, Yian Du, Litao Yang, Maowei Ni, Ruibin Jiang, (unknown), Hang Lv, (unknown), Shengjie Zhang, Jiang‐Jiang Qin, Xiangdong Cheng	24
12	Polyphyllin B Suppresses Gastric Tumor Growth by Modulating Iron Metabolism and Inducing Ferroptosis 2023 ·International Journal of Biological Sciences ·Can Hu, (unknown), Jingli Xu, (unknown), Yuan Li, Jiahui Chen, (unknown), Yanqiang Zhang, Jing Han, Tao Lu, Jinyun Dong, Jiang‐Jiang Qin, Zhiyuan Xu, Xiangdong Cheng	36
13	Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review breakdown → 2023 ·Pharmacology & Therapeutics ·Jinyun Dong, Yuan Li, Can Hu, Xiangdong Cheng, Jiang‐Jiang Qin	85
14	An updated patent review of protein arginine N-methyltransferase inhibitors (2019–2022) 2022 ·Expert Opinion on Therapeutic Patents ·Jinyun Dong, (unknown), Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang‐Yang Ye	16
15	S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation 2022 ·Bioorganic & Medicinal Chemistry ·Haobin Li, Maohua Cai, (unknown), Dehua Yu, Jing Yang, Wen-Kai Yu, (unknown), Xiaoqing Guan, Jiang‐Jiang Qin, Jinyun Dong	15
16	Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation 2021 ·Journal of Medicinal Chemistry ·Jinyun Dong, Xiangdong Cheng, Weidong Zhang, Jiang‐Jiang Qin	157
17	Protein degradation technology: a strategic paradigm shift in drug discovery 2021 ·Journal of Hematology & Oncology ·Haobin Li, Jinyun Dong, Maohua Cai, Zhiyuan Xu, Xiangdong Cheng, Jiang‐Jiang Qin	60
18	Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma 2014 ·British Journal of Cancer ·Sheng Han, (unknown), (unknown), Jinyun Dong, Y Liu, Yinde Huang, Tianxi Jiang, Anhua Wu	274
19	Search for novel histone deacetylase inhibitors. Part II: Design and synthesis of novel isoferulic acid derivatives 2014 ·Bioorganic & Medicinal Chemistry ·Wen Lu, Fang Wang, Tao Zhang, Jinyun Dong, (unknown), Ping Su, Yaling Shi, Jie Zhang	16
20	Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: Design, synthesis and biological evaluation 2013 ·Bioorganic & Medicinal Chemistry ·Chen Wang, (unknown), Jinyun Dong, Yanmin Zhang, Ping Su, Yaling Shi, Jie Zhang	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact